Estrogen is the single most important hormone driving hip widening, and it does so primarily by reshaping the bony pelvis itself during puberty and early adulthood. The female pelvis begins diverging from the male pelvis around the onset of puberty and keeps expanding in key dimensions until roughly age 25 to 30, a timeline that tracks closely with estradiol levels. But estrogen’s influence on hip width goes beyond bone: it also directs where the body stores fat, layering tissue around the hips and thighs in a pattern that amplifies the skeletal changes underneath.
How the Pelvis Changes During Puberty
Before puberty, male and female pelvises are nearly identical in shape and proportion. The divergence begins when estradiol levels rise in girls, typically between ages 8 and 13. Estrogen receptors are concentrated in specific regions of the pelvic bones, and when activated, they stimulate growth at the sites most relevant to the birth canal: the distance between the hip joints, the width of the pelvic inlet, and the subpubic angle. Research in evolutionary anthropology confirms that female pelves expand more than males’ due to estrogen and relaxin produced and employed by the tissues of the pelvic region.
1PubMed. Expanding the evolutionary explanations for sex differences in the human skeletonThe hormone receptors that make this possible are not exclusive to puberty. Studies of primate and human fetal tissue show that sex differences in the distribution of estrogen and androgen receptors in the pelvis develop before birth. The hardware is already in place; puberty simply floods it with the hormonal signal that triggers remodeling.
2PubMed Central. Sex differences in the pelvis did not evolve de novo in modern humansThe Expansion Window Stays Open Longer Than You Might Think
A common assumption is that skeletal growth stops in the late teens when the growth plates in the long bones fuse. Pelvic development follows a different timeline. Research tracking pelvic dimensions across age groups shows that obstetrically relevant pelvic measurements keep expanding until about age 25 to 30 in women, well after height growth has stopped. This extended window of pelvic widening is tied to sustained estradiol levels during peak reproductive years, and the pelvis reaches its widest, most birth-friendly configuration during the period of maximum fertility.
3PubMed Central. Developmental evidence for obstetric adaptation of the human female pelvisThis means a woman’s hips at 18 are not yet at their final width. The continued remodeling through the twenties is subtle but real, and it helps explain why many women notice their body shape shifting during their early to mid-twenties even though they are long past puberty. The process is estrogen-dependent: when estradiol levels eventually decline around menopause, pelvic dimensions begin to shift again, as we will see later.
What Aromatase Deficiency Reveals
Some of the strongest evidence for estrogen’s role in skeletal development comes from rare cases where the body cannot produce it at all. Aromatase is the enzyme that converts androgens into estrogen. Men with aromatase deficiency, who produce essentially zero estrogen, show dramatically abnormal skeletal development: extremely tall stature from unfused growth plates, severely delayed bone maturation, and diffuse bone loss. Their pelves show a lack of normal development, with absent epiphyseal fusion visible on imaging.
4PubMed Central. Aromatase deficiencyThese cases act as a natural experiment. Without estrogen, even genetic males (who normally have narrower pelves) fail to achieve normal pelvic bone maturation. When treated with estrogen replacement, their bone age advances and mineral density improves. The implication is clear: estrogen is not just one factor among many in pelvic and skeletal development; it is a gatekeeper for normal bone maturation in both sexes, and especially for the widening pattern seen in females.
Fat Redistribution and the Appearance of Wider Hips
Bone is only part of the story. Estrogen also acts on adipose tissue, directing fat storage preferentially to the hips, thighs, and buttocks rather than the abdomen. This “gynoid” fat pattern is a hallmark of female body composition from puberty through the premenopausal years. The hip circumference you measure with a tape includes both bone width and the soft tissue layered on top, so estrogen’s effect on fat placement substantially contributes to overall hip size.
Research into the determinants of body fat distribution confirms that sex hormones play a clear role in where fat accumulates, though much remains unknown about the genetic regulation at the level of individual fat deposits.
5PubMed Central. Determinants of body fat distribution in humans may provide insight about obesity-related health risksThis dual mechanism means that even when two women have the same skeletal hip width, differences in estrogen-driven fat patterning can make their hip measurements vary by several centimeters. It also means that changes in estrogen levels, whether from menopause, medications, or hormone therapy, can alter hip circumference through soft tissue alone, without any change in bone structure.
Evidence from Gender-Affirming Hormone Therapy
Transgender medicine has provided some of the clearest real-world data on what estrogen can and cannot do to hip dimensions at different life stages, because researchers can track the same individuals before and after hormonal changes.
In adolescents, timing turns out to be everything. A study tracking transgender youth who received puberty-suppressing treatment followed by gender-affirming hormones found that those who started treatment in early puberty saw their hip bone geometry shift toward the pattern typical of their experienced gender. Trans women whose puberty was paused early and who then received estrogen developed wider subperiosteal width at the hip, tracking closer to a typical female curve. But those who started treatment in mid or late puberty remained within the range of their sex assigned at birth.
6PubMed Central. Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early PubertyIn adults, the bone story is different but the soft tissue story is consistent. A multicenter study of adult trans women on estrogen-based hormone therapy found that waist-to-hip ratio decreased, mainly because hip circumference increased by about 3 centimeters. That gain comes primarily from fat redistribution rather than skeletal remodeling, since adult bones respond much less to hormonal signals than adolescent bones do.
7European Journal of Endocrinology. Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective studyThe takeaway from this research is that estrogen can meaningfully reshape bone structure at the hip, but only during the narrow developmental window when the skeleton is still actively growing. After that, estrogen’s influence on hip width works through soft tissue.
The Pelvis Keeps Widening with Age, Independent of Estrogen
Here is something unexpected: the bony pelvis continues to get wider throughout adulthood, in both men and women, long after estrogen levels in women have started declining. A radiographic study measuring pelvic dimensions across a wide age range found a steady increase in width at the trochanters (the bony bumps you feel at the widest part of the hips), at the iliac wings, and between the femoral heads. The pelvis widened by more than 20 millimeters between ages 20 and 80.
8PubMed. Surprising evidence of pelvic growth (widening) after skeletal maturityBecause this widening happens in both sexes at a similar rate, it is not driven by estrogen. It appears to be a mechanical and age-related process, possibly reflecting slow remodeling of bone in response to decades of weight-bearing. The practical upshot: if your hips feel wider in your forties or fifties, part of that is skeletal, and estrogen is not the cause. The bones themselves are slowly spreading apart over time.
What Pregnancy Does to the Pelvis
Pregnancy introduces a hormonal surge that goes well beyond normal estrogen levels. Relaxin, a hormone produced by the ovaries and placenta, loosens the ligaments that hold the pelvic joints together. This allows the pelvis to become temporarily more flexible, which helps accommodate the baby during delivery. The sacroiliac joints and the pubic symphysis can loosen enough to cause noticeable changes in how the hips feel and move.
Research has found that women with severe pelvic pain and joint instability during late pregnancy tend to have significantly higher serum relaxin levels than pain-free controls, suggesting that the degree of pelvic loosening varies with individual hormone levels.
9Lancet. Serum relaxin and pelvic pain of pregnancySome women report that their hips remain permanently wider after pregnancy. Whether this reflects lasting skeletal change or persistent soft-tissue changes is debated. Anecdotally, many women find they cannot fit into pre-pregnancy jeans even after returning to their pre-pregnancy weight, and the explanation likely involves some combination of ligament laxity that does not fully reverse, hormonal shifts in fat distribution, and the slow age-related bone widening described above happening to coincide with the childbearing years.
When Estrogen Drops at Menopause
The menopausal transition offers a kind of natural experiment in reverse: what happens to the hip region when estrogen levels plummet? The answer is a shift in both bone and fat that reshapes the hip area substantially.
On the fat side, the drop in estrogen triggers a redistribution away from the gynoid pattern (hips and thighs) toward central adiposity. Postmenopausal women show higher total body fat, higher visceral fat, and a significantly increased waist-to-hip ratio compared to premenopausal women of similar age, reflecting a shift toward abdominal fat storage.
10PubMed Central. The Impact of the Menopausal Transition on Body Composition and Abdominal Fat RedistributionOn the bone side, the slow age-related widening continues, but estrogen’s protective effects on bone density decline. This can lead to changes in pelvic shape over time as the bones become less dense and more susceptible to remodeling forces. The pelvic research mentioned earlier found that the female pelvis reaches its most favorable obstetric dimensions during peak fertility and then begins to shift as estradiol declines, suggesting the hormone’s influence is not just a one-time developmental event but an ongoing maintenance signal.
3PubMed Central. Developmental evidence for obstetric adaptation of the human female pelvisFor many women, the net result of menopause is that hip circumference does not necessarily shrink, but the ratio of hip to waist changes: the waist catches up. The body becomes more apple-shaped and less pear-shaped, even if absolute hip measurements stay similar.
Genetics and Individual Variation
Estrogen is the primary driver, but it is not the only factor determining how wide your hips end up. Twin studies of pelvic morphology have found a significant genetic component to pelvic dimensions, but with an interesting wrinkle: bitrochanteric breadth (the widest measurement across the hips at the level of the greater trochanters) had the highest cultural heritability, meaning that environmental factors like nutrition and physical activity played an unusually large role in determining that specific measurement.
11PubMed. Genetic basis of human female pelvic morphology: a twin studyLarger-scale genetic research has identified roughly 179 independent genetic loci associated with pelvic shape, with heritability estimates of about 25 to 40 percent for various pelvic dimensions. One particularly interesting finding: the subpubic angle, a key birth-canal measurement, shows a genetic correlation between the sexes that is significantly less than one, meaning the genes influencing this trait operate differently in men and women. This is consistent with sex-specific selection pressure acting on pelvic shape.
12bioRxiv. The genetic architecture and evolutionary consequences of the human pelvic formWhat this means practically is that two women with identical estrogen levels can end up with noticeably different hip widths depending on their genetics, their nutritional history during puberty, and their overall body composition. Estrogen sets the direction, but the magnitude varies.
The Evolutionary Story Is More Complicated Than the Textbook Version
For decades, the standard evolutionary explanation for why female hips are not even wider was the “obstetrical dilemma”: the idea that the human pelvis is a compromise between a birth canal wide enough for a large-brained baby and a structure narrow enough for efficient bipedal walking. The implication was that wider hips would make walking and running less efficient, so natural selection held pelvic width in check.
That story has taken a beating in recent years. Biomechanical research directly testing whether pelvic width predicts walking or running efficiency found that it does not. Wider-hipped individuals were no less efficient at either walking or running than narrower-hipped ones, and women and men were equally efficient overall.
13PLoS ONE. A Wider Pelvis Does Not Increase Locomotor Cost in Humans, with Implications for the Evolution of ChildbirthThis finding undercuts the classic trade-off model. If wide hips do not actually cost anything in terms of movement efficiency, the constraint on pelvic width must come from somewhere else, or perhaps it is not as constrained as previously thought. Reviews of the obstetrical dilemma have noted that the old compromise model was always based more on assumption than data, and that recent kinematic studies have failed to support it.
14PubMed Central. Evolution of the human pelvis and obstructed labor: new explanations of an old obstetrical dilemmaThe emerging view treats estrogen-driven pelvic plasticity as the more interesting part of the story. Rather than being locked in a permanent compromise, the female pelvis appears to be a responsive structure that tracks hormonal signals across a woman’s lifetime, reaching peak birth-canal dimensions during peak fertility and shifting afterward. This developmental plasticity may itself be the evolutionary solution to the problem of fitting a large-headed baby through a bipedal pelvis, rather than a fixed anatomical trade-off.
Biomechanical Ripple Effects of Hip Width
The wider female pelvis has consequences beyond childbirth. The greater distance between the hip joints changes the angle at which the femur meets the knee, creating what biomechanists call the “Q angle.” A larger Q angle shifts the alignment of the entire lower limb and is one reason women experience certain knee injuries at higher rates than men.
Research on adolescent girls found that earlier menarche, which correlates with earlier estrogen exposure and earlier pelvic changes, was associated with retention of a wider walking base of support and more valgus (inward-angled) knee biomechanics during walking. Girls who went through puberty earlier tended to have greater inward knee angles at foot strike and during the stance phase of walking.
15PubMed Central. Relationships Between Age at Menarche, Walking Gait Base of Support, and Stance Phase Frontal Plane Knee Biomechanics in Adolescent GirlsThis connection between estrogen-driven hip width and downstream joint mechanics is one reason sports medicine researchers pay close attention to puberty timing in female athletes. The wider pelvis is not a liability for walking efficiency, as we saw, but it does shift knee alignment in ways that may increase vulnerability to certain soft-tissue injuries like ACL tears. Understanding that link starts with recognizing that estrogen is reshaping not just hip width but the entire geometry of the lower body.
Oral Contraceptives and Joint Laxity
Given estrogen’s role in bone remodeling and soft tissue properties, you might expect that oral contraceptives, which alter circulating estrogen levels, would affect joint laxity around the hip and knee. The research on this is surprisingly clear and somewhat anticlimactic. A study comparing peripheral joint laxity in women using oral contraceptives to non-users found no significant differences in laxity measurements at the knee or hand. Anterior knee displacement was similar in both groups, averaging between about 6 and 8 millimeters, and finger joint flexibility was virtually identical.
16Journal of Orthopaedic & Sports Physical Therapy. Self-reported oral contraceptive use and peripheral joint laxityThis makes sense when you consider that the estrogen levels in standard oral contraceptives are considerably lower than the levels driving skeletal remodeling during puberty or the relaxin-dominated hormonal environment of pregnancy. Taking the pill does not meaningfully change your hip width or your joint looseness, and concerns that it might are not well supported by the evidence. The hormonal signal required to reshape bone is sustained, potent, and works within a developmental window that the birth control pill does not replicate.